Glickman Mark A - Insider Non-Derivative Transactions at NeuroBo Pharmaceuticals, Inc. (NRBO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2024, Glickman Mark A's relationship to NeuroBo Pharmaceuticals, Inc. (NRBO) is Director, and currently has 9,740 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NRBO insiders.
Data Source: SEC.
Glickman Mark A - Insider Non-Derivative Transactions of NRBO Common Stock
Glickman Mark A - Insider Non-Derivative Transactions at NRBO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2024 | Acquisition -- (Common Stock) | 5051 | 0 | 9740 |
| Jul 28, 2023 | Acquisition -- (Common Stock) | 25000 | 0 | 25000 |
| Jul 28, 2023 | Acquisition -- (Common Stock) | 12500 | 0 | 37500 |